Menu

D.N.A. Biomedical Solutions Ltd.

Complementary equity research reports on D.N.A. Biomedical Solutions Ltd..

Report Type

Publish Date

link

Q2 2020 Report

25 August 2020

Q2 2020 Report – Hebrew Appendix

25 August 2020

Q1 2020 Report

16 June 2020

Q1 2020 Report – Hebrew Appendix

16 June 2020

Q4 2019 Report

25 April 2020

Q4 2019 Report – Hebrew Appendix

25 April 2020

Q3 2019 Report

18 December 2019

Q3 2019 Report – Hebrew Appendix

18 December 2019

Q2 2019 Report

17 September 2019

Q2 2019 Report – Hebrew Appendix

17 September 2019

Q1 2019 Report

1 July 2019

Q1 2019 Report – Hebrew Appendix

1 July 2019

2018 Annual Report

22 May 2019

2018 Annual Report – Hebrew Appendix

22 May 2019

Immediate Report

12 December 2018

Q2 2018 Report

12 September 2018

Q2 2018 Report – Hebrew Appendix

12 September 2018

Immediate Report

1 July 2018

Immediate Report – Hebrew Appendix

1 July 2018

Q1 2018 Update

10 June 2018

Q1 2018 Update – Hebrew Appendix

10 June 2018

Q2 2017 Update

11 April 2018

Q4 2017 Update – Hebrew Appendix

11 April 2018

Q3 2017 Update

8 February 2018

Q3 2017 Update – Hebrew Appendix

8 February 2018

Initiation of Coverage

10 October 2017

Initiation of Coverage – Hebrew Appendix

10 October 2017

Have Questions?

We have Answers.

Schedule a Complimentary Growth Strategy
Dialogue with an Industry Expert

Call Frost & Sullivan Icon

877.GoFrost

(877.463.7678)

Email Frost & Sullivan

myfrost@frost.com

X